SNA
52
2
GM
85
2
PCG
74
2
BAX
38
-12
ZTS
21
2
INTC
43
6
ITW
37
-2
JBHT
65
2
BRK.B
33
-14
PH
62
2
DHR
66
2
FLS
61
13
NUE
58
7
AN
50
7
AVB
34
-3
GILD
56
6
OXY
40
2
PSA
35
-11
FSLR
73
15
SCHW
64
6
SNA
52
2
GM
85
2
PCG
74
2
BAX
38
-12
ZTS
21
2
INTC
43
6
ITW
37
-2
JBHT
65
2
BRK.B
33
-14
PH
62
2
DHR
66
2
FLS
61
13
NUE
58
7
AN
50
7
AVB
34
-3
GILD
56
6
OXY
40
2
PSA
35
-11
FSLR
73
15
SCHW
64
6
Financhill
Back

Guggenheim Strategic Opportunities Fund Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Buy
59

GOF
Guggenheim Strategic Opportunities Fund

Last Price:
$12.24
Seasonality Move:
0.55%
Sell
34

MNPR
Monopar Therapeutics, Inc.

Last Price:
$69.11
Seasonality Move:
25.93%
Buy
59
Guggenheim Strategic Opportunities Fund (GOF) is a Buy

Is Guggenheim Strategic Opportunities Fund a Buy, Sell or Hold?

  • The current Guggenheim Strategic Opportunities Fund [GOF] share price is $12.25. The Score for GOF is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • GOF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $68.63. The Score for MNPR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GOF Stock Price Chart

What is Guggenheim Strategic Opportunities Fund's stock price today?

  • The Guggenheim Strategic Opportunities Fund share price today is $12.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GOF is experiencing buying pressure, which is a positive indicator for future bullish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $68.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

GOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.21 Sell
Relative Strength Index (14 RSI): 43.93 Sell
Chaikin Money Flow: 1752434 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.99 - 12.39) Buy
Bollinger Bands (100): (12.73 - 15.13) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.61 Sell
Relative Strength Index (14 RSI): 37.25 Sell
Chaikin Money Flow: 166161 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (72.18 - 85.74) Sell
Bollinger Bands (100): (45.57 - 89.21) Buy

GOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.14 Buy
20-day SMA: 12.18 Buy
50-day SMA: 12.89 Sell
200-day SMA: 14.39 Sell
8-day EMA: 12.15 Buy
20-day EMA: 12.26 Sell
50-day EMA: 12.85 Sell
200-day EMA: 14.13 Sell

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.35 Sell
20-day SMA: 78.65 Sell
50-day SMA: 81.47 Sell
200-day SMA: 52.32 Buy
8-day EMA: 71.44 Sell
20-day EMA: 75.9 Sell
50-day EMA: 76.79 Sell
200-day EMA: 56.68 Buy

Guggenheim Strategic Opportunities Fund Earnings Growth & GOF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Guggenheim Strategic Opportunities Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):